Gulick A M, Fahl W E
McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.
Pharmacol Ther. 1995 May;66(2):237-57. doi: 10.1016/0163-7258(94)00079-i.
The glutathione S-transferases are a family of Phase II detoxication enzymes that catalyze the conjugation of glutathione to a large variety of electrophilic compounds. In the 1990s, there have been many advances regarding the function of these enzymes in protecting a cell from the toxic effects of these electrophiles. The complexity of this enzyme family has been realized and much work has been performed to identify the specific roles played by individual isozymes in resistance to a variety of agents. Likewise, the determination of the crystal structure of these enzymes has allowed the identification of specific amino acid residues that are involved in the catalysis of important reactions. The important role that these enzymes play in carcinogenesis and in drug resistance has warranted an attempt to bring together these different subfields of glutathione S-transferase biology to investigate possible ways that this system could be regulated in therapeutically useful ways. In this report, we have reviewed the recent advances and ways in which this knowledge could be utilized in the advancement of the treatment of cancer.
谷胱甘肽S-转移酶是一类II相解毒酶,可催化谷胱甘肽与多种亲电化合物结合。在20世纪90年代,关于这些酶在保护细胞免受这些亲电试剂毒性作用方面的功能有了许多进展。人们已经认识到这个酶家族的复杂性,并开展了大量工作来确定各个同工酶在对多种药物的抗性中所起的具体作用。同样,这些酶晶体结构的确定使得能够识别参与重要反应催化的特定氨基酸残基。这些酶在致癌作用和耐药性中所起的重要作用促使人们尝试将谷胱甘肽S-转移酶生物学的这些不同子领域整合起来,以研究以治疗上有用的方式调节该系统的可能途径。在本报告中,我们回顾了最近的进展以及如何利用这些知识来推进癌症治疗。